Explore more publications!
Mississippi Healthcare Reporter
Submit Press Release

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 13, 2025

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom
November 13, 2025

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom

Indeterminate GlobeNewswire
Allsup Helps Individuals Apply For SSDI Benefits After Longest Government Shutdown Ends
November 13, 2025

Allsup Helps Individuals Apply For SSDI Benefits After Longest Government Shutdown Ends

Indeterminate GlobeNewswire
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
November 13, 2025

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

Indeterminate GlobeNewswire
Aptose Reports Third Quarter 2025 Results
November 13, 2025

Aptose Reports Third Quarter 2025 Results

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI
November 13, 2025

Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI

Indeterminate GlobeNewswire
SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights
November 13, 2025

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
November 13, 2025

Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Allsup Highlights Medical Complexity, Economic Strain For Social Security Disability Claims Involving Diabetes
November 13, 2025

Allsup Highlights Medical Complexity, Economic Strain For Social Security Disability Claims Involving Diabetes

Indeterminate GlobeNewswire
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
November 13, 2025

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Indeterminate GlobeNewswire
Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
November 13, 2025

Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
November 13, 2025

Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

Indeterminate GlobeNewswire
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
November 13, 2025

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
November 13, 2025

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

Indeterminate GlobeNewswire
NANOBIOTIX annonce les avancées de sa plateforme de nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes
November 13, 2025

NANOBIOTIX annonce les avancées de sa plateforme de nanoprimer Curadigm avec une mise à jour des plans de développement pour son pipeline interne et des collaborations externes

Indeterminate GlobeNewswire
Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations
November 13, 2025

Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations

Indeterminate GlobeNewswire
Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights
November 13, 2025

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Indeterminate GlobeNewswire
Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area
November 13, 2025

Sienna Reports Third Quarter 2025 Financial Results and Continues Growth in Greater Toronto Area

Indeterminate GlobeNewswire
Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
November 13, 2025

Alumis Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Indeterminate GlobeNewswire
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
November 13, 2025

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Indeterminate GlobeNewswire
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025
November 13, 2025

Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions